BMY announcements Bristol-myers Squibb Company announcements and dividends declared NYSE
Bristol-myers Squibb Company Complete list of announcements declared & dividend announcements by Bristol-myers Squibb Company BMY
Bristol-myers Squibb Company BMY listed on NYSE and deals in Health Care Major PharmaceuticalsAnnouncements and dividends declared by Bristol-myers Squibb Company BMY
Compugen's stock jumps after Bristol Myers Squibb completes million investment into the company
Shares of Compugen Ltd. gained 13.4% in premarket trading on Thursday after Bristol Myers Squibb Co. completed a million investment in the company. Compugen's stock is down 48.1% so far this year, while the broader S&P 500 is up 25.2%. Market Pulse
Announcement as on 11 November 2021
Bristol Myers Squibb says sales of Revlimid, Eliquis increased in the third quarter
Shares of Bristol Myers Squibb Co. gained 0.6% in premarket trading on Wednesday after the drug maker beat expectations for the quarter and saw sales rise for two of its top-selling products. The company had earnings of .5 billion, or 69 cents per share
Announcement as on 27 October 2021
Bristol Myers: FDA Accepts SBLA For Opdivo Plus Yervoy, Opdivo Plus Chemotherapy In ESCC Patients
(RTTNews) - Bristol Myers Squibb (BMY) announced Monday that the U.S. Food and Drug Administration has accepted the supplemental Biologics License Applications or sBLA for both Opdivo (nivolumab) in combination with Yervoy (ipilimumab) and Opdivo in combin
Announcement as on 27 September 2021
Bristol Myers Reports FDA Priority Review For Relatlimab And Nivolumab Combination
(RTTNews) - Bristol Myers Squibb (BMY) said FDA has accepted for priority review the Biologics License Application for relatlimab and nivolumab fixed-dose combination in the treatment of adult and pediatric patients with unresectable or metastatic melanoma
Announcement as on 20 September 2021
Bristol Myers stock falls toward 6-month low, set to suffer longest losing streak in 3 1/2 years
Shares of Bristol Myers Squibb Co. slumped 1.7% in midday trading Thursday toward a six-month low, putting them on track to suffer the longest losing streak in 3 1/2 years. The stock is headed for a ninth-straight loss, and has declined 7.8% during that s
Announcement as on 16 September 2021
Announcements by Bristol-myers Squibb Company first page | Next page | Prev page |
BMY Bristol-myers Squibb Company current price & indicator signals
Recent prices of BMY Bristol-myers Squibb Company are as follows: Daily volume is divided by 10 day averaged volume
| Date | Close | Range | Change % | Volume |
| 06 Mon Apr 2026 | 59.33 | 58.77 to 59.63 | -0.44% | 0.94 times |
| 02 Thu Apr 2026 | 59.59 | 59.10 to 61.00 | -3.51% | 1.02 times |
| 01 Wed Apr 2026 | 61.76 | 60.61 to 62.23 | 1.83% | 0.68 times |
| 31 Tue Mar 2026 | 60.65 | 59.92 to 61.13 | 1.49% | 1.51 times |
| 30 Mon Mar 2026 | 59.76 | 58.54 to 60.06 | 2.08% | 0.88 times |
| 27 Fri Mar 2026 | 58.54 | 58.37 to 59.69 | -1.46% | 0.93 times |
| 26 Thu Mar 2026 | 59.41 | 58.54 to 59.51 | 0.8% | 0.36 times |
| 25 Wed Mar 2026 | 58.94 | 57.79 to 59.39 | 2.7% | 1.07 times |
| 24 Tue Mar 2026 | 57.39 | 56.45 to 57.69 | 0.68% | 1.42 times |
| 23 Mon Mar 2026 | 57.00 | 57.00 to 58.25 | -0.8% | 1.2 times |
| 20 Fri Mar 2026 | 57.46 | 56.91 to 58.55 | -1.14% | 0.94 times |
| 19 Thu Mar 2026 | 58.12 | 58.09 to 59.64 | -2.66% | 0.78 times |
Videos related to: BMY announcements Bristol-myers Squibb Company announcements and dividends declared NYSE
Hindi Video Most Important Stock Market Video. No Success Without This Formula
Hindi Video What Is Needed To Succeed In Stock Markets
- NYSE Screeners
- NYSE Daily Screener
- NYSE Weekly Screener
- NYSE Monthly Screener
- Support & Resistance
- NYSE Shares Near Support
- NYSE Shares Near Resistance


